A Study to Assess the Changes in the Hematological Manifestation in Chronic Kidney Disease Patients
Creators
- 1. Professor, Department of Nephrology, Sardar Patel Medical College, Bikaner, Rajasthan
Description
Chronic kidney disease (CKD) is a global public health problem, with greater burden and very high cost of care especially in developing countries like India. The objective of this study is to assess the hematological profile of our subjects with CKD. Patients admitted as inpatients in the Department of medicine at Sardar Patel Medical College Hospital, during the period of 2018-2021 were included in this study.13.00% patients had microcytic hypochromic anemia, 91.00% patients had normocytic normochromic, 25.00% patients had relative neutrophila, 11.00% patients had leucocytosisand 9.00% patients had thrombocytopenia. Anemia is a very common clinical manifestation in patients of Chronic Kidney Disease. The most common morphological type of Anemia seen in our study was Normocytic normochromic type. Management of anemia with Iron and Erythropoeitin therapy is an important therapeutic intervention in the optimum treatment of patients with Chronic Kidney Disease.
Abstract (English)
Chronic kidney disease (CKD) is a global public health problem, with greater burden and very high cost of care especially in developing countries like India. The objective of this study is to assess the hematological profile of our subjects with CKD. Patients admitted as inpatients in the Department of medicine at Sardar Patel Medical College Hospital, during the period of 2018-2021 were included in this study.13.00% patients had microcytic hypochromic anemia, 91.00% patients had normocytic normochromic, 25.00% patients had relative neutrophila, 11.00% patients had leucocytosisand 9.00% patients had thrombocytopenia. Anemia is a very common clinical manifestation in patients of Chronic Kidney Disease. The most common morphological type of Anemia seen in our study was Normocytic normochromic type. Management of anemia with Iron and Erythropoeitin therapy is an important therapeutic intervention in the optimum treatment of patients with Chronic Kidney Disease.
Files
IJPCR,Vol15,Issue7,Article173.pdf
Files
(305.7 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:eed03bafaffa0e6ba057c38abb613649
|
305.7 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-02-27
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue7,Article173.pdf
- Development Status
- Active
References
- 1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO clinical 1290 practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 1291 Suppl 3, 1-150 (2013). 1292 2. Zoccali, C. et al. 2. The systemic nature of CKD. Nat Rev Nephrol 2017;13, 344-358 3. Locatelli F, Pozzoni P, Del Vecchio L. Recombinant human epoetin beta in the treatment of renal anemia. Therapeutics and clinical risk management. 2007;3(3):433. 4. Eschbach JW Jr, Funk D, Adamson J, Kuhn I, Scribner BH and Finch CA. Erythropoesis in patients with renal failure undergoing chronic dialysis. N. Eng J. Med.1967;276(12): 653-8. 5. Ratcliffe PJ. Molecular biology of erythropoietin. Kidney international. 1993;44(4):887-904. 6. Akinsola A, Durosinmi MO, Akinola NO. The haematological profile of Nigerians with chronic renal failure. Africa J Medic and medical Sci. 2000;29(1):13-6. 7. Oluboyede OA, Williams AIO (1995). Serum ferritin and other Iron Indices in Adult Nigerians with Chronic Renal Failure: Review of Management of Anaemia. Afr J. Med. Med. Sci.; 24:231-237. 8. Sardenberg C, Suassuna P, Andreoli MCC, Watanabe R, Dalboni MA, Manfredi SR et al. Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function. Nephrol Dial Transplant 2006;21:160–5. 9. Agarwal SK, Dash SC, Irshad M, Raju S, Singh R, Pandey RM. Prevalence of chronic renal failure in adults in Delhi, India. Nephrol Dial Transplant 2005; 20(8): 1638-42. 10. Talwar VK, Gupta HL, Shashinarayan. Clinicohaematological profile in chronic renal failure. J Assoc Physicians India 2002;50:228-33.